Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis.
Extracellular matrix deposition and tissue scarring characterize the process of fibrosis. Transforming growth factor beta (TGFβ) and Insulin-like growth factor binding protein-3 (IGFBP-3) have been implicated in the pathogenesis of fibrosis in various tissues by inducing mesenchymal cell proliferati...
Main Authors: | Ximena D Ruiz, Logan R Mlakar, Yukie Yamaguchi, Yunyun Su, Adriana T Larregina, Joseph M Pilewski, Carol A Feghali-Bostwick |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3416749?pdf=render |
Similar Items
-
Insulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditions.
by: Sara M Garrett, et al.
Published: (2019-01-01) -
The membrane-associated adaptor protein DOK5 is upregulated in systemic sclerosis and associated with IGFBP-5-induced fibrosis.
by: Hidekata Yasuoka, et al.
Published: (2014-01-01) -
IGFBP-5 Promotes Fibrosis Independently of Its Translocation to the Nucleus and Its Interaction with Nucleolin and IGF.
by: Yunyun Su, et al.
Published: (2015-01-01) -
Fibroblasts in fibrosis: novel roles and mediators
by: Ryan Thomas Kendall, et al.
Published: (2014-05-01) -
Immunohistochemical analysis of syndecan-1 in leukoplakia and oral submucous fibrosis
by: Sushant S Kamat, et al.
Published: (2013-01-01)